Product image of Mirtazapin Sandoz (Mirtazapine) supplied by GNH India

Mirtazapin Sandoz

Active Ingredient:
Mirtazapine
Origin:
EU

Mirtazapin Sandoz (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapin Sandoz, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It treats major depressive disorder in adult patients.

GNH India supplies Mirtazapin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mirtazapine, marketed as Mirtazapin Sandoz, is used within the antidepressant drug class to manage depressive disorders.

  • Major depressive disorder: reduces depressive symptoms and improves mood in adult patients.
  • Depressive episodes associated with major depressive disorder: alleviates symptoms during acute episodes.
  • Treatment‑resistant depression (adjunctive): may be considered when first‑line agents are insufficient.

How It Works

  • Mirtazapin Sandoz acts as an antagonist at central presynaptic α2‑adrenergic receptors, increasing norepinephrine release, and blocks 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic transmission. Its potent H1‑receptor antagonism contributes to its sedative and appetite‑stimulating effects, collectively improving depressive symptoms.

Side Effects

Mirtazapin Sandoz may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Sedation or drowsiness.
  • Increased appetite and weight gain.
  • Dry mouth.
  • Constipation.
  • Dizziness.
  • Orthostatic hypotension.

Serious or Rare Side Effects

  • Agranulocytosis or severe neutropenia.
  • Hepatic dysfunction or jaundice.
  • Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome).
  • Suicidal thoughts or behavior, especially early in treatment.
  • Serotonin syndrome when combined with other serotonergic agents.
  • Uncontrolled hypertension.

Precautions & Warnings

Before prescribing Mirtazapin Sandoz, clinicians should consider several safety precautions.

  • Assess depression severity: confirm diagnosis before initiating therapy.
  • Monitor for suicidal thoughts: especially during early treatment or dose changes.
  • Use caution in hepatic impairment: dose adjustment may be required.
  • Elderly patients: increased risk of sedation and falls.
  • Avoid abrupt discontinuation: taper dose to minimise withdrawal symptoms.
  • Store at ambient temperature: keep in original packaging, protect from moisture.

Avoid Interactions

Mirtazapin Sandoz can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis; discontinue MAOI at least 14 days before.
  • Other serotonergic agents (e.g., SSRIs, SNRIs, tramadol): potential serotonin syndrome.
  • Central nervous system depressants (e.g., benzodiazepines, alcohol): enhanced sedation and respiratory depression.

Moderate Interactions (Monitor Closely)

  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase mirtazapine plasma levels.
  • Antihypertensive drugs: additive blood‑pressure‑lowering effect.
  • Anticholinergic agents: increased anticholinergic burden may worsen dry mouth and constipation.

Frequently Asked Questions

Mirtazapin Sandoz contains the antidepressant mirtazapine and is indicated for the treatment of major depressive disorder in adult patients. It helps alleviate depressive symptoms such as low mood, loss of interest, and sleep disturbances.

Mirtazapine increases neurotransmission by blocking presynaptic α2‑adrenergic receptors, which raises norepinephrine release, and by antagonising 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic activity. Its strong H1‑receptor antagonism also contributes to sedation and appetite stimulation.

The dose of Mirtazapin Sandoz is individualized by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. The prescriber determines the appropriate starting dose and any subsequent adjustments.

Safety data for mirtazapine in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine belongs to the NaSSA class, differing from SSRIs and SNRIs by its receptor‑blocking profile, which often results in stronger sedative and appetite‑stimulating effects. It may be preferred when insomnia or weight loss are prominent, whereas SSRIs are typically chosen for their more neutral side‑effect profile.

Store the tablets at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep out of reach of children and do not use if the packaging is damaged.

Mirtazapin Sandoz is taken orally, usually once daily in the evening. Tablets should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include agranulocytosis, severe hepatic injury, hypersensitivity reactions such as Stevens‑Johnson syndrome, serotonin syndrome when combined with other serotonergic drugs, and the emergence or worsening of suicidal thoughts, particularly during the initial weeks of therapy.

Mirtazapin Sandoz is contraindicated in patients who have used monoamine oxidase inhibitors within the past 14 days or who have a known hypersensitivity to mirtazapine or any of its excipients. Caution is also advised for individuals with severe hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mirtazapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT